Mitochondrial Ca 2+ in Cancer Growth and Metabolism
Journal of Cellular Physiology · 2025
DOI: 10.1002/jcp.70093 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cellular Physiology, 2025. Verfasst von Jillian S Weissenrieder und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Mitochondria, Neoplasms, Calcium, Calcium Signaling. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 317 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Cancer is a leading cause of death in developed countries, despite many breakthroughs in targeted small molecule and immunotherapeutic interventions. A deeper understanding of the characteristics and processes that underlie malignancy will enable us to develop more effective therapeutic options to improve patient outcomes. One particular area of interest is in cancer cell metabolism. Even as early as the 1920s, Otto Warburg recognized dysregulated metabolism in cancerous cells. Altered metabolism may provide targetable nutrient dependencies for further clinical development, either by nutrient restriction or pathway inhibition. More recently, researchers have observed an increasingly strong linkage between altered mitochondrial Ca 2+ homeostasis and tumor cell metabolism, with strong implications for therapeutic targeting. In this review, we summarize the literature surrounding mitochondrial Ca 2+ homeostasis, metabolism, and cancer, as well as providing a discussion of the potential for mitochondrial Ca 2+ modulation as an anticancer therapeutic modality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
- Department of Cell and Developmental Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Jillian S Weissenrieder
Förderung
- NCI NIH HHS
Zitieren
APA
Weissenrieder, J. S., & Kevin Foskett, J. (2025). Mitochondrial Ca 2+ in Cancer Growth and Metabolism. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.70093
Vancouver
Weissenrieder JS, Kevin Foskett J. Mitochondrial Ca 2+ in Cancer Growth and Metabolism. Journal of Cellular Physiology. 2025. doi:10.1002/jcp.70093
BibTeX
@article{Weissenrieder2025,
author = {Weissenrieder, Jillian S and Kevin Foskett, J},
title = {Mitochondrial Ca 2+ in Cancer Growth and Metabolism},
journal = {Journal of Cellular Physiology},
year = {2025},
doi = {10.1002/jcp.70093}
}
EUVIMED